FVIII inhibitors in haemophilia A patients who are considered as previously treated patients.

被引：0
|
作者：
von Auer, C [1 ]
Krause, M [1 ]
Miesbach, W [1 ]
Scharrer, I [1 ]
Asmelash, G [1 ]
Stier-Brueck, I [1 ]
机构：
[1] Univ Frankfurt, Dept Internal Med 1, D-6000 Frankfurt, Germany
来源：
BLOOD | 2004年 / 104卷 / 11期
关键词：
D O I：
10.1182/blood.V104.11.4022.4022
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4022
引用
收藏
页码：91B / 92B
页数：2
相关论文
共 50 条
  • [1] Factor VIII inhibitors in haemophilia A patients who are considered as previously treated patients
    von Auer, C
    Oldenburg, J
    Krause, M
    Miesbach, W
    Scharrer, I
    BLOOD, 2005, 106 (11) : 107B - 107B
  • [2] Impact of FVIII product change in severe haemophilia A patients previously treated with plasma-derived FVIII
    Mingot, M. E.
    Heiniger, A., I
    Garcia, M.
    Fernandez, J. A.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 1124 - 1124
  • [3] Inhibitor development against FVIII in previously treated patients with haemophilia A - A retrospective data collection
    Siegmund, B.
    Pollmann, H.
    Richter, H.
    Orlovic, M.
    Gottstein, S.
    Klamroth, R.
    HAMOSTASEOLOGIE, 2010, 30 (4A): : S37 - S39
  • [4] The Epidemiology of FVIII Inhibitors in Indian Haemophilia A Patients
    Patricia Pinto
    Tejashree Shelar
    Vidhya Nawadkar
    Darshana Mirgal
    Alfiya Mukaddam
    Preethi Nair
    Priyanka Kasatkar
    Tejasvita Gaikwad
    Shahnaz Ali
    Anshul Jadli
    Rucha Patil
    Anita Parihar
    Sharda Shanbhag
    Bipin Kulkarni
    Kanjaksha Ghosh
    Shrimati Shetty
    Indian Journal of Hematology and Blood Transfusion, 2014, 30 : 356 - 363
  • [5] The Epidemiology of FVIII Inhibitors in Indian Haemophilia A Patients
    Pinto, Patricia
    Shelar, Tejashree
    Nawadkar, Vidhya
    Mirgal, Darshana
    Mukaddam, Alfiya
    Nair, Preethi
    Kasatkar, Priyanka
    Gaikwad, Tejasvita
    Ali, Shahnaz
    Jadli, Anshul
    Patil, Rucha
    Parihar, Anita
    Shanbhag, Sharda
    Kulkarni, Bipin
    Ghosh, Kanjaksha
    Shetty, Shrimati
    INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION, 2014, 30 (04) : 356 - 363
  • [6] Prophylactic Treatment of Severe Haemophilia A Patients with Inhibitors to FVIII with Peglip-FVIII
    Timofeeva, Margarita
    Zozulya, Nadezhda I.
    Pospelova, Tatiana
    Kosinova, Marina V.
    Kurtov, Igor
    Tuddenham, Edward
    Ling, Gavin
    BLOOD, 2021, 138
  • [7] Prophylactic Treatment of Severe Haemophilia a Patients with Inhibitors to FVIII with Peglip-FVIII
    Tuddenham, Edward
    Wolf-Garraway, Richard
    Ling, Gavin
    BLOOD, 2022, 140 : 5617 - 5618
  • [8] Natural history and clinical characteristics of inhibitors in previously treated haemophilia A patients: a case series
    Iorio, A.
    Barbara, A. M.
    Makris, M.
    Fischer, K.
    Castaman, G.
    Catarino, C.
    Gilman, E.
    Kavakli, K.
    Lambert, T.
    Lassila, R.
    Lissitchkov, T.
    Mauser-Bunschoten, E.
    Mingot-Castellano, M. E.
    Ozdemir, N.
    Pabinger, I.
    Parra, R.
    Pasi, J.
    Peerlinck, K.
    Rauch, A.
    Roussel-Robert, V.
    Serban, M.
    Tagliaferri, A.
    Windyga, J.
    Zanon, E.
    HAEMOPHILIA, 2017, 23 (02) : 255 - 263
  • [9] Antiretroviral therapy for previously treated patients.
    Montaner, JSG
    Mellors, JW
    NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (06): : 452 - 455
  • [10] Antibody profile in Indian severe haemophilia A patients with and without FVIII inhibitors
    Pinto, Patricia
    Shetty, Shrimati
    Lacroix-Desmazes, Sebastien
    Bayry, Jagadeesh
    Kaveri, Srini
    Ghosh, Kanjaksha
    IMMUNOLOGY LETTERS, 2016, 169 : 93 - 97
12345